Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Adam H Schechter. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Adam H Schechter telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:DVA / DaVita Inc. Director 4,699
US:LH / Labcorp Holdings Inc. President & CEO, Director 93,319
US:MRK / Merck & Co., Inc. EVP & Pres-Global Human Health 0
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Adam H Schechter. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Adam H Schechter sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-08-19 2025-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 369 4,699 8.52
2025-08-13 2025-08-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,643 93,319 -5.70 266.78 -1,505,440 24,895,643
2025-05-16 2025-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 348 4,330 8.74
2025-05-13 2025-05-12 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,105 98,962 -5.81 248.73 -1,518,497 24,614,818
2025-03-31 2025-03-27 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -13,584 105,067 -11.45 231.67 -3,147,005 24,340,872
2025-03-31 2025-03-27 4 LH LABCORP HOLDINGS INC.
Common Stock
A - Award 30,469 118,651 34.55
2025-03-18 2025-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 349 3,982 9.61
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,226 88,182 -1.37 245.14 -300,542 21,616,935
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 2,963 89,408 3.43
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,121 86,445 -6.61 244.62 -1,497,319 21,146,176
2025-02-10 2025-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,345 92,566 -1.43 246.27 -331,233 22,796,229
2025-02-10 2025-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 3,250 93,911 3.58
2025-02-10 2025-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,240 90,661 -1.35 247.74 -307,198 22,460,356
2025-02-10 2025-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 4,460 91,901 5.10
2024-11-19 2024-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 312 3,633 9.39
2024-11-13 2024-11-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,189 87,441 -6.61 243.47 -1,506,836 21,289,260
2024-08-19 2024-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 333 3,321 11.14
2024-05-17 2024-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 363 2,988 13.83
2024-03-29 2024-03-27 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -31,799 93,630 -25.35 216.57 -6,886,709 20,277,449
2024-03-29 2024-03-27 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 72,435 125,429 136.69
2024-03-19 2024-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 366 2,625 16.20
2024-02-13 2024-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,231 52,994 -2.27 227.45 -279,991 12,053,485
2024-02-13 2024-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,964 54,225 5.78
2024-02-08 2024-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,149 51,261 -2.19 223.71 -257,043 11,467,598
2024-02-08 2024-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,250 52,410 6.61
2024-02-06 2024-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -822 49,160 -1.64 221.54 -182,106 10,890,906
2024-02-06 2024-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,094 49,982 6.60
2023-11-17 2023-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 529 2,259 30.58
2023-08-17 2023-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 475 1,730 37.85
2023-05-17 2023-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 516 1,255 69.82
2023-04-03 2023-03-30 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -18,646 46,888 -28.45 224.70 -4,189,756 10,535,734
2023-04-03 2023-03-30 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 42,353 65,534 182.71
2023-03-17 2023-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 658 739 812.35
2023-02-14 2023-02-13 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,170 23,181 -4.80 248.13 -290,312 5,751,902
2023-02-14 2023-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,656 24,351 12.24
2023-02-07 2023-02-06 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,368 21,695 -5.93 244.50 -334,476 5,304,428
2023-02-07 2023-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,507 23,063 17.93
2023-02-06 2023-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -805 19,556 -3.95 254.99 -205,267 4,986,584
2023-02-06 2023-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,773 20,361 15.77
2022-11-16 2022-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 81 81
2022-11-03 2022-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -893 17,588 -4.83 222.56 -198,746 3,914,385
2022-11-03 2022-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,007 18,481 12.18
2022-09-29 3 DVA DAVITA INC.
No securities are beneficially owned
0
2022-02-15 2022-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 28,100 28,100
2022-02-15 2022-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 7,970 19,031 72.05
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -3,507 11,061 -24.07
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,412 16,474 -7.89 277.48 -391,802 4,571,206
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,507 17,886 24.39
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,773 14,568 -15.99
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -803 14,379 -5.29 273.18 -219,364 3,928,055
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,773 15,182 22.35
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,007 17,341 -10.37
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -886 12,409 -6.66 288.78 -255,859 3,583,471
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,007 13,295 17.78
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -3,506 19,348 -15.34
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,028 11,288 -8.35 223.78 -230,046 2,526,029
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,506 12,316 39.80
2021-02-04 2021-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 29,000 29,000
2021-02-04 2021-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 8,320 22,854 57.25
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,006 14,534 -12.13
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -885 8,810 -9.13 207.23 -183,399 1,825,696
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,006 9,695 26.09
2020-02-14 2020-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,227 16,540 -6.91
2020-02-14 2020-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,227 7,689 18.99
2020-02-06 2020-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 45,600 45,600
2020-02-06 2020-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 10,520 17,767 145.16
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 65,100 65,100
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 24,800 24,800
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 6,020 7,247 490.63
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,227 1,227
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,038 0 -100.00
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,038 6,462 19.14
2019-02-14 2018-11-19 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
G - Gift -610 5,424 -10.11
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -277,879 0 -100.00
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -145,135 0 -100.00 73.66 -10,691,181
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -132,744 145,135 -47.77 73.98 -9,819,764 10,736,391
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 277,879 277,879 39.29 10,917,866 10,917,866
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -100,000 0 -100.00
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -7,360 55,406 -11.73 70.18 -516,511 3,888,286
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -100,000 0 -100.00 70.18 -7,017,780
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 100,000 100,000 36.56 3,656,000 3,656,000
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -100,000 100,000 -50.00
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -34,094 62,766 -35.20 61.00 -2,079,785 3,828,819
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -100,000 0 -100.00 61.00 -6,100,160
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 100,000 100,000 36.56 3,656,000 3,656,000
2018-05-08 2018-05-04 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 139,063 139,063
2018-03-01 2018-02-27 4 MRK Merck & Co., Inc.
Common Stock
A - Award 34,094 34,094 54.72 1,865,624 1,865,624
2018-02-14 2018-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,038 1,038
2018-02-09 2018-02-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
S - Sale X -1,263 6,034 -17.31 169.29 -213,813 1,021,496
2018-02-09 2018-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,263 0 -100.00
2018-02-09 2018-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,263 7,297 20.93
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,994 200,000 -20.32
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,608 62,766 -44.64 61.63 -3,118,971 3,868,267
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,994 0 -100.00 61.63 -3,142,760
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,994 50,994 36.56 1,864,341 1,864,341
2017-12-18 2017-12-15 4 MRK Merck & Co., Inc.
Common Stock
G - Gift -750 113,374 -0.66
2017-05-09 2017-05-05 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 162,625 162,625
2017-04-10 2017-02-27 4/A MRK Merck & Co., Inc.
Common Stock
A - Award 37,758 37,758 65.85 2,486,364 2,486,364
2017-04-04 2017-04-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -53,850 116,336 -31.64 63.48 -3,418,166 7,384,507
2017-03-01 2017-02-27 4 MRK Merck & Co., Inc.
Common Stock
A - Award 39,970 39,970 65.85 2,632,024 2,632,024
2017-02-13 2017-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,560 1,263 -55.26
2017-02-13 2017-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,560 6,034 34.87
2017-02-09 2017-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,263 2,823 80.96
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -26,135 0 -100.00
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -10,200 250,994 -3.91
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -36,335 0 -100.00 63.73 -2,315,699
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 10,200 36,335 39.03 36.56 372,912 1,328,408
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 26,135 26,135 33.49 875,261 875,261
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -39,200 26,135 -60.00
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -39,200 0 -100.00 62.61 -2,454,308
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 39,200 39,200 33.49 1,312,808 1,312,808
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,000 0 -100.00 57.69 -2,884,415
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,000 50,000 44.30 2,215,000 2,215,000
2016-05-12 2016-05-10 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 258,065 258,065
2016-03-15 2016-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,237 1,560 -44.23
2016-03-15 2016-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,237 4,474 38.21
2016-02-24 2016-02-22 4 MRK Merck & Co., Inc.
Common Stock
A - Award 37,223 37,223 50.77 1,889,812 1,889,812
2016-02-11 2016-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,560 2,797 126.11
2015-05-11 2015-05-11 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -10,634 0 -100.00 60.44 -642,768
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Restricted Stock Unit
M - Exercise -19,343 0 -100.00 59.86 -1,157,872
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Common Stock
F - Taxes -8,709 10,634 -45.02 59.86 -521,321 636,551
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 19,343 19,343
2015-05-05 2015-05-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 235,294 235,294
2015-03-13 2015-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,237 1,237
2015-02-25 2015-02-23 4 MRK Merck & Co., Inc.
Common Stock
A - Award 22,198 22,198 58.30 1,294,143 1,294,143
2015-02-12 2015-02-10 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,503 0 -100.00
2015-02-12 2015-02-10 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,503 3,237 86.68
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -19,200 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -74,200 0 -100.00 62.48 -4,636,224
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 74,200 7.23 34.47 172,350 2,557,674
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 19,200 69,200 38.40 35.09 673,728 2,428,228
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,000 50,000 44.19 2,209,500 2,209,500
2014-11-25 2014-11-24 4 MRK Merck & Co. Inc.
Phantom Stock
S - Sale -2,779 0 -100.00
2014-08-25 2014-08-25 4 MRK Merck & Co. Inc.
Common Stock
S - Sale X -22,000 70,795 -23.71 59.70 -1,313,380 4,226,396
2014-05-15 2014-05-13 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,503 1,503
2014-05-14 2014-05-14 4 MRK Merck & Co. Inc.
Common Stock
S - Sale X -10,527 0 -100.00 55.91 -588,584
2014-05-13 2014-05-09 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 209,078 209,078
2014-05-12 2014-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,593 0 -100.00
2014-05-12 2014-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,593 1,734 1,129.79 98.96 157,643 171,597
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -19,147 0 -100.00 58.22 -1,114,738
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -8,620 10,527 -45.02 58.22 -501,856 612,882
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 19,147 19,147
2014-02-26 2014-02-24 4 MRK Merck & Co. Inc.
Common Stock
A - Award 22,287 22,287 56.18 1,252,084 1,252,084
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -3,000 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -2,500 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -12,500 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock - 401(k) Plan
I - Other -4,040 0 -100.00 55.70 -225,049
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -18,000 0 -100.00 55.61 -1,000,935
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 2,500 18,000 16.13 47.39 118,475 853,020
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 3,000 15,500 24.00 45.41 136,230 703,855
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 12,500 12,500 48.24 603,000 603,000
2013-05-16 2013-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,593 1,593
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -12,188 0 -100.00 44.98 -548,216
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -5,488 22,416 -19.67 44.98 -246,850 1,008,252
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 12,188 27,904 77.55
2013-05-08 2013-05-06 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 244,767 244,767
2013-04-03 2013-04-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 141 141
2013-02-27 2013-02-25 4 MRK Merck & Co. Inc.
Common Stock
A - Award 8,136 15,568 109.47 42.52 345,943 661,951
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -10,670 0 -100.00 41.42 -441,951
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -3,238 7,432 -30.35 41.42 -134,118 307,833
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 10,670 10,670
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -61,200 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -56,300 14,900 -79.07 45.60 -2,567,257 679,434
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 71,200 7.55 28.42 142,100 2,023,504
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 66,200 8.17 31.84 159,200 2,107,808
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 61,200 61,200 23.45 1,435,140 1,435,140
2012-05-04 2012-05-02 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 277,879 277,879
2012-05-04 2012-05-02 4 MRK Merck & Co. Inc.
Restricted Stock Unit
A - Award 19,343 19,343
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -11,475 0 -100.00 38.27 -439,148
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -4,535 7,035 -39.20 38.27 -173,554 269,226
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 11,475 11,570 12,089.51
2012-03-01 2012-02-28 4 MRK Merck & Co. Inc.
Common Stock
A - Award 9,194 9,194 38.38 352,866 352,866
2010-05-06 3 MRK Merck & Co. Inc.
Common Stock - 401(k) Plan
9,804
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)